Your browser doesn't support javascript.
loading
T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational study.
Schettini, F; Conte, B; Buono, G; De Placido, P; Parola, S; Griguolo, G; Fabi, A; Bighin, C; Riccardi, F; Cianniello, D; De Laurentiis, M; Puglisi, F; Pelizzari, G; Bonotto, M; Russo, S; Frassoldati, A; Pazzola, A; Montemurro, F; Lambertini, M; Guarneri, V; Cognetti, F; Locci, M; Generali, D; Conte, P; De Placido, S; Giuliano, M; Arpino, G; Del Mastro, L.
Affiliation
  • Schettini F; Department of Clinical Medicine and Surgery, University of Naples 'Federico II', Naples, Italy; Translational Genomics and Targeted Therapies in Solid Tumors Group, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; SOLTI Breast Cancer Research Group, Barcelona, Spain. Ele
  • Conte B; SOLTI Breast Cancer Research Group, Barcelona, Spain; Medical Oncology Unit 2, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Buono G; Oncology Unit, San Rocco Hospital, Sessa Aurunca, Italy.
  • De Placido P; Department of Clinical Medicine and Surgery, University of Naples 'Federico II', Naples, Italy.
  • Parola S; Department of Clinical Medicine and Surgery, University of Naples 'Federico II', Naples, Italy.
  • Griguolo G; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padua, Italy; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy.
  • Fabi A; Division of Medical Oncology 1, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Bighin C; Medical Oncology Unit 2, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Riccardi F; Medical Oncology, 'A. Cardarelli' Hospital, Naples, Italy.
  • Cianniello D; National Cancer Institute Fondazione 'G. Pascale', Naples, Italy.
  • De Laurentiis M; National Cancer Institute Fondazione 'G. Pascale', Naples, Italy.
  • Puglisi F; Department of Medicine (DAME), University of Udine, Udine, Italy; Department of Clinical Oncology, CRO Aviano National Cancer Institute, Aviano, Italy.
  • Pelizzari G; Department of Clinical Oncology, CRO Aviano National Cancer Institute, Aviano, Italy.
  • Bonotto M; Department of Oncology, ASUFC University Hospital, Udine, Italy.
  • Russo S; Department of Oncology, ASUFC University Hospital, Udine, Italy.
  • Frassoldati A; Oncology Unit, University Hospital St. Anna, Ferrara, Italy.
  • Pazzola A; Division of Medical Oncology, AOU Sassari, Sassari, Italy.
  • Montemurro F; Depertment of Medical Oncology, Candiolo Cancer Institute, Candiolo, Italy.
  • Lambertini M; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa, Italy; Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Guarneri V; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padua, Italy; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy.
  • Cognetti F; Department of Clinic and Molecular Medicine, 'La Sapienza' University of Rome, Rome, Italy.
  • Locci M; Department of Neuroscience, Reproductive Medicine, Odontostomatology, University of Naples 'Federico II', Naples, Italy.
  • Generali D; Breast Cancer Unit, Azienda Socio Sanitaria Territoriale di Cremona, Cremona, Italy; Department of Medical, Surgery and Health Sciences, University of Trieste, Trieste, Italy.
  • Conte P; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padua, Italy; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy.
  • De Placido S; Department of Clinical Medicine and Surgery, University of Naples 'Federico II', Naples, Italy.
  • Giuliano M; Department of Clinical Medicine and Surgery, University of Naples 'Federico II', Naples, Italy.
  • Arpino G; Department of Clinical Medicine and Surgery, University of Naples 'Federico II', Naples, Italy.
  • Del Mastro L; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa, Italy; U.O.S.D. Breast Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
ESMO Open ; 6(2): 100099, 2021 04.
Article in En | MEDLINE | ID: mdl-33819752
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Observational_studies / Risk_factors_studies Limits: Female / Humans Country/Region as subject: Europa Language: En Journal: ESMO Open Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Observational_studies / Risk_factors_studies Limits: Female / Humans Country/Region as subject: Europa Language: En Journal: ESMO Open Year: 2021 Type: Article